Caplight Directory>Companies>Vona Oncology-preview>Vonaoncology


Vona Oncology

Vona Oncology

Private
Aurora, ColoradoHealthcare & Life Scienceshttps://vonaoncology.com/

Last Round

Grant

Nov 20, 2025

Total Funding Raised

$2.89M

Company Overview

Vona Oncology is a biopharmaceutical company developing targeted therapeutics to treat aggressive cancers such as triple-negative breast cancer, ovarian cancer, and melanoma.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts, Revenue Share

AI Layer

Non-AI

Keywords

oncology therapeuticssmall molecule therapeuticstargeted therapytriple-negative breast cancerTNBCclinical stage biopharmafirst-in-class therapeuticdrug discoveryovarian cancermelanomahard-to-treat cancersIND-enabling studiesnon-dilutive fundingSBIR grantpharma licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vona Oncology Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Vona Oncology Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantNov 20, 2025
GrantMay 20, 2021
View all Funding Rounds

Vona Oncology Investors

Notable investors and investment history

InvestorRounds
NIH RADxGrant
Colorado Office of Economic Development and International TradeGrant
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 2, 2025

    Monthly visitors increased 222% MoM.

  • Nov 20, 2025

    $250K grant from Colorado Office of Economic Development and International Trade.

View all signals

Vona Oncology Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Vona Oncology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Vona Oncology's valuation, stock price, and market status.

Firmographic Details

HeadquartersAurora, Colorado
Employee Range2
Year Founded2018
Last FundingNov 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.